Signals
Desmoid Tumours Are Not Benign to the People Living With Them
FDA has accepted Immunome’s NDA for varegacestat in adults with progressing desmoid tumours. The label may say non-metastatic. The burden can still be brutal.
Cervical Cancer Cannot Be Left Waiting at the Edge of the ADC Era
Mental Health Patients Need Care, Not Surveillance
ESC Cardio-Oncology 2026: Cancer therapy is getting smarter. Cardiac protection is still playing catch-up.
ENDO 2026 reveals the GLP-1 revolution’s real challenge: delivery
Prostate Cancer Access Moves Into the Veterans System
Mental Health Patients Need Care, Not Surveillance
Cardio-oncology demand is rising, but training gaps are holding systems back
Cholesterol prevention is moving earlier. Is Europe ready to treat inherited risk before adulthood?
Prostate Cancer Access Moves Into the Veterans System
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.